(Q37973144)

26 August 2017

title

Treatment of mixed bipolar states (English)

1 reference

26 August 2017

3

Xenia Gonda

0 references

Dimitris Kontis

0 references

author name string

Konstantinos N Fountoulakis

1

1 reference

26 August 2017

Dimitrios Kontis

2

1 reference

26 August 2017

Melina Siamouli

4

1 reference

26 August 2017

Lakshmi N Yatham

5

1 reference

26 August 2017

publication date

5 January 2012

1 reference

The International Journal of Neuropsychopharmacology

26 August 2017

published in

1 reference

26 August 2017

volume

15

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

1015-1026

1 reference

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Treatment of mixed mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Olanzapine versus placebo in acute mania: treatment responses in subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Acute dysphoric mania: treatment response to olanzapine versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Extending indications for long-term pharmacotherapy: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Pharmacotherapy of bipolar mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Relevance of the catatonic syndrome to the mixed manic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

The prevalence of mixed episodes during the course of illness in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Incidence and significance of mixed affective states in a bipolar population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

A double-blind comparison of valproate and lithium in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Signs and symptoms of mania in pure and mixed episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Improvement of Positive and Negative Syndrome Scale cognitive score associated with olanzapine treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Diagnosis and treatment of mixed mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

Practice guideline for the treatment of patients with bipolar disorder (revision)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Differential Outcome of Pure Manic, Mixed/Cycling, and Pure Depressive Episodes in Patients With Bipolar Illness

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Specificity of mixed affective states: clinical comparison of dysphoric mania and agitated depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Mania: differential effects of previous depressive and manic episodes on response to treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Association of recurrent suicidal ideation with nonremission from acute mixed mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Significance of mixed features in acute mania

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001817

7 January 2021

10.1017/S1461145711001817

Identifiers

DOI

1 reference

release_bivridadmbfovkg3u3jpqkdbyy

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bivridadmbfovkg3u3jpqkdbyy

24 November 2022

mapped directly with Wikidata item

1 reference